Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.

M Stein, S Keshav, N Harris, S Gordon - The Journal of experimental …, 1992 - rupress.org
Expression of the macrophage mannose receptor is inhibited by interferon gamma (IFN-
gamma), a T helper type 1 (Th-1)-derived lymphokine. Interleukin 4 (IL-4), a Th-2 lymphocyte …

Multiple defects of immune cell function in mice with disrupted interferon-γ genes

DK Dalton, S Pitts-Meek, S Keshav, IS Figari, A Bradley… - Science, 1993 - science.org
Interferon-γ (IFN-γ) is a pleiotrophic cytokine with immunomodulatory effects on a variety of
immune cells. Mice with a targeted disruption of the IFN-γ gene were generated. These mice …

Crohn's disease and the NOD2 gene: a role for paneth cells

S Lala, Y Ogura, C Osborne, SY Hor, A Bromfield… - Gastroenterology, 2003 - Elsevier
BACKGROUND & AIMS:: The NOD2 gene, which is strongly associated with susceptibility to
Crohn's disease (CD) of the terminal ileum, interacts with bacterial lipopolysaccharide (LPS) …

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease

NR West, AN Hegazy, BMJ Owens, SJ Bullers… - Nature medicine, 2017 - nature.com
Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis
(UC), are complex chronic inflammatory conditions of the gastrointestinal tract that are driven …

Paneth cells: leukocyte-like mediators of innate immunity in the intestine

S Keshav - Journal of leukocyte biology, 2006 - academic.oup.com
Paneth cells are secretory intestinal epithelial cells located at the base of the crypts of
Lieberkühn in the small intestine. They display prominent cytoplasmic granules, containing …

CCR9 antagonism: potential in the treatment of inflammatory bowel disease

E Wendt, S Keshav - Clinical and experimental gastroenterology, 2015 - Taylor & Francis
Inflammatory Bowel Disease (IBD), mainly comprising Crohn's disease (CD) and ulcerative
colitis (UC), is a chronic condition that primarily affects the intestine and is characterized by …

Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up

RV Bryant, DC Burger, J Delo, AJ Walsh, S Thomas… - Gut, 2016 - gut.bmj.com
Background Endoscopic mucosal healing is an established treatment target for UC, yet the
value of achieving histological remission remains unclear. Aims To evaluate histological …

[HTML][HTML] Circulating and tissue-resident CD4+ T cells with reactivity to intestinal microbiota are abundant in healthy individuals and function is altered during …

AN Hegazy, NR West, MJT Stubbington, E Wendt… - Gastroenterology, 2017 - Elsevier
Background & Aims Interactions between commensal microbes and the immune system are
tightly regulated and maintain intestinal homeostasis, but little is known about these …

The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock

R Haworth, N Platt, S Keshav, D Hughes… - The Journal of …, 1997 - rupress.org
During gram-negative bacterial infections, lipopolysaccharide (LPS) stimulates primed
macrophages (Mφ) to release inflammatory mediators such as tumor necrosis factor (TNF)-α …

Medical management of Crohn's disease

JRF Cummings, S Keshav, SPL Travis - Bmj, 2008 - bmj.com
Crohn's disease is a chronic, relapsing and remitting inflammatory condition of the
gastrointestinal tract. Treatment has changed radically over the past decade with the …